Persistent infection with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a patient with untreated human immunodeficiency virus (HIV)

Article Immunology

Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020

Jonathon D. Kotwa et al.

Summary: The infrequent recovery of infectious SARS-CoV-2 virus from the environment suggests that the risk to healthcare workers from air and near-patient surfaces in acute care hospital wards is likely limited.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Multidisciplinary Sciences

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Jeroen J. A. van Kampen et al.

Summary: The study found that the median duration of shedding infectious virus in COVID-19 patients is 8 days, dropping below 5% after 15.2 days post onset of symptoms. High viral loads are associated with infectious SARS-CoV-2 isolation, while high serum neutralizing antibody titres are associated with non-infectious SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Immunology

Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19

Daniel Owusu et al.

Summary: The study found that most COVID-19 patients remained positive for SARS-CoV-2 for >= 10 days after symptom onset, but individuals with mild to moderate COVID-19 are unlikely to be infectious >= 10 days after symptom onset. Participants under 18 had shorter shedding resolution times, while those over 50 had longer shedding resolution times compared to those aged 18-49.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Medicine, General & Internal